Prepulse inhibition
Prepulse inhibition (PPI) is a neurological phenomenon in which a weaker pre-stimulus (or prepulse) inhibits the reaction of an organism to a subsequent strong startling stimulus (pulse). The reduction of the amplitude of startle reflects the ability of the nervous system to temporarily adapt to a strong sensory stimulus when a preceding weaker signal is given to warn the organism. This process is thought to measure the sensory gating capacity of neural circuits, and is used as a research tool in psychophysiological research to understand the role of inhibitory processes in normal and abnormal cognitive function.
Mechanism[edit]
The mechanism of PPI is not fully understood, but it is known to involve a network of brain regions including the auditory system, the limbic system, and the frontal cortex. The prepulse stimulus is thought to activate inhibitory interneurons in these regions, which then inhibit the response to the subsequent startling stimulus.
Clinical significance[edit]
PPI is often reduced in individuals with certain neurological and psychiatric disorders, such as schizophrenia, bipolar disorder, and Parkinson's disease. This reduction in PPI is thought to reflect a deficit in sensory gating, which may contribute to the cognitive and perceptual disturbances associated with these disorders.
Research[edit]
Research on PPI has provided insights into the neural mechanisms underlying sensory gating and has potential implications for the development of new treatments for disorders characterized by sensory gating deficits.
See also[edit]
References[edit]
-
Diagram illustrating the concept of prepulse inhibition
-
Equipment used for measuring startle response
-
Research setup for studying prepulse inhibition
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
